Grünenthal GmbH

Grünenthal GmbH logo
🇩🇪Germany
Ownership
Private
Established
1946-01-01
Employees
1K
Market Cap
-
Website
http://www.grunenthal.com

Safety of Intravenous Neridronic Acid in CRPS

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-11-23
Last Posted Date
2019-11-21
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
580
Registration Number
NCT02972359
Locations
🇺🇸

US004: Northwestern University - Feinberg School of Medicine - Rehabilitation Institute of Chicago (RIC), Chicago, Illinois, United States

🇺🇸

US033: Alliance Research Centers, Laguna Hills, California, United States

🇺🇸

US005: International Clinical Research Institute, Overland Park, Kansas, United States

and more 43 locations

Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint Pain

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-10-02
Last Posted Date
2021-07-16
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
23
Registration Number
NCT02566564
Locations
🇧🇪

SGS Antwerpen, Antwerpen, Belgium

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

First Posted Date
2015-03-30
Last Posted Date
2018-05-09
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
459
Registration Number
NCT02402530
Locations
🇺🇸

Site US119 - G & L Research, Foley, Alabama, United States

🇺🇸

Site US117 - Valley Pain Consultants, Scottsdale, Arizona, United States

🇺🇸

Site US172 - Core Healthcare Group, Cerritos, California, United States

and more 56 locations

Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery

First Posted Date
2014-08-26
Last Posted Date
2018-10-23
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
271
Registration Number
NCT02225353
Locations
🇨🇱

Universidad de Chile, Hospital Barros Luco, Santiago, Chile

🇨🇱

Complejo Asistencial Dr. Sótero del Río (CASR), Santiago, Chile

🇨🇱

Universidad de Chile, Hospital Clínico San Borja Arriarán, Santiago, Chile

and more 1 locations

Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2014-08-20
Last Posted Date
2018-01-29
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
40
Registration Number
NCT02221674
Locations
🇵🇱

PL001, Łódź, Poland

🇺🇸

US004, Philadelphia, Pennsylvania, United States

🇺🇸

US001, Palo Alto, California, United States

and more 4 locations

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

First Posted Date
2014-05-30
Last Posted Date
2019-09-12
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
73
Registration Number
NCT02151682
Locations
🇭🇺

HU001, Budapest, Hungary

🇧🇬

BG006, Sofia, Bulgaria

🇨🇱

CL004, Santiago, Chile

and more 20 locations

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

First Posted Date
2014-03-07
Last Posted Date
2020-01-18
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
216
Registration Number
NCT02081391
Locations
🇺🇸

US003, Dallas, Texas, United States

🇵🇱

PL005, Lodz, Poland

🇵🇱

PL002, Lublin, Poland

and more 40 locations

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

First Posted Date
2013-04-24
Last Posted Date
2016-02-24
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
367
Registration Number
NCT01838616
Locations
🇩🇪

DE005, Bad Saarow, Germany

🇩🇪

DE007, Berlin, Germany

🇩🇪

DE021, Berlin, Germany

and more 47 locations

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

First Posted Date
2012-12-19
Last Posted Date
2016-07-06
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
444
Registration Number
NCT01752322
Locations
🇬🇧

GBR001, Glasgow, United Kingdom

🇮🇹

ITA004, Firenze, Italy

🇧🇷

BRA002, Itajai, Brazil

and more 39 locations
© Copyright 2024. All Rights Reserved by MedPath